Biogen Inc. Profile Avatar - Palmy Investing

Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…

Drug Manufacturers - General
US, Cambridge [HQ]

Insiders

Transactions

Track non-derivative insider transactions.
i = Indirect d = Direct cs = Common Stock
Reported Owner(s) Position Now Transaction Date Type Position Change Extra
Singhal Priya
Head of Development
$54,264,761 d cs
10% Holder
12/09/24
S
110 x $157.21 = $17,293.10
Singhal Priya
Head of Development
$55,364,761 d cs
10% Holder
12/06/24
F
206 x $157.78 = $32,502.68
Kramer Robin
Chief Accounting Officer
$65,777,483 d cs
10% Holder
12/06/24
M
351 x $0 = $0
Kramer Robin
Chief Accounting Officer
$64,077,483 d cs
10% Holder
12/06/24
F
170 x $157.78 = $26,822.60
Singhal Priya
Head of Development
$57,424,761 d cs
10% Holder
12/06/24
M
426 x $0 = $0

Get PRO Today

With PRO you will unlock 81 more insider transactions for Biogen Inc.